Sai Life Sciences has informed that Sai Life Sciences along with Agility Life Sciences and Centrix Pharma Solutions, has announced the launch of an Integrated CMC Partnership aimed at accelerating drug development for innovator biopharma companies. This strategic collaboration brings together the complementary strengths of the three organizations in Chemistry, Manufacturing and Controls (CMC), offering end-to-end services from API development to clinical manufacturing. Through this partnership, customers will have access to integrated drug substance and drug product development, helping them move efficiently from preclinical studies to first-in-human (FIH) clinical trials and beyond.
The above information is a part of company’s filings submitted to BSE.
